Recent Updates
Recently added Catalysts
QTI Positive Sentiment

QT Imaging to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Thursday, November 5, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: QT Imaging announced that CFO Jay Jennings will present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum. The event takes place on November 11, 2026, in New York City. The company focuses on radiation-free imaging technology for breast health management.

Market Sentiment Analysis

POSITIVE FACTORS

  • QT Imaging is participating in a notable industry forum.
  • The company focuses on innovative, radiation-free imaging technology.
  • CFO Jay Jennings will present, highlighting company leadership.

Full Press Release Details

PETALUMA, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced its participation in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum, taking place November 11, 2026, in New York City. Chief Financial Officer Jay Jennings will deliver a company presentation and participate

Frequently Asked Questions

When will QT Imaging present at the forum?

QT Imaging will present on November 11, 2026.

Who will represent QT Imaging at the event?

CFO Jay Jennings will deliver the company presentation.

What is the focus of QT Imaging's technology?

The company focuses on radiation-free imaging technology for breast health.

Where is the Canaccord Genuity Forum taking place?

The forum will be held in New York City.

ShareAdd on Google
Tags: QTI QT Imaging breast health medical device Canaccord Genuity imaging technology
Last updated: Nov 5, 2026

Biotech snapshot

Cash runway
$11M liquidity · $2M/mo burn
~4 mo
High dilution risk